Dinactin: A New Antitumor Antibiotic with Cell Cycle Progression and Cancer Stemness Inhibiting Activities in Lung Cancer

Lung cancer, especially non-small cell lung cancer (NSCLC), is one of the most complex diseases, despite the existence of effective treatments such as chemotherapy and immunotherapy. Since cancer stem cells (CSCs) are responsible for chemo- and radio-resistance, metastasis, and cancer recurrence, fi...

Descripción completa

Detalles Bibliográficos
Autores principales: Rawangkan, Anchalee, Wongsirisin, Pattama, Pook-In, Grissana, Siriphap, Achiraya, Yosboonruang, Atchariya, Kiddee, Anong, Chuerduangphui, Jureeporn, Reukngam, Nanthawan, Duangjai, Acharaporn, Saokaew, Surasak, Praphasawat, Ratsada
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9774622/
https://www.ncbi.nlm.nih.gov/pubmed/36551502
http://dx.doi.org/10.3390/antibiotics11121845

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9774622/
https://www.ncbi.nlm.nih.gov/pubmed/36551502
http://dx.doi.org/10.3390/antibiotics11121845

Ejemplares similares